1 Napoli MD, Singh P. Is plasma fibrinogen useful in

evaluating ischemic stroke patients?:why, how, and

when[J]. Stroke, 2009, 40:1549-1552.

2 Mau r iel lo A, Sangiorgi G, Palmier i G, et al.

Hyperfibrinogenemia is associated with specific

histocytological composition and complicatious of

atherosclerotic carotid plaques in patients affected

by transient ischemic attacks[J]. Circulation, 2000,

101:744-750.

3 曹勇军, 吴延华, 刘春风. 纤维蛋白(原)及其降解产物

对共培养血管内皮细胞tPA和PAI-1表达的影响[J]. 中

华心血管病杂志, 2008, 36:62-67.

4 刘慧慧, 曹勇军, 张艳林, 等. 纤维蛋白原、纤维蛋白及

其降解产物对共培养血管平滑肌细胞表型转换的影

响[J]. 中国临床神经科学, 2008, 16:369-374.

5 吴延华, 曹勇军, 刘春风. 组织型纤溶酶原激活物及其

抑制剂与动脉粥样硬化的关系[J]. 国际脑血管病杂志,

2007, 15:534-537.

6 Mosesson MW. Fibrinogen and fibrin structure and

functions[J]. J Thromb Haemost, 2005, 3:1894-1904.

7 Cho J, Mosher DF. Enhancement of thrombogenesis

by plasma fibronectin cross-linked to fibrin and

assembled in platelet thrombi[J]. Blood, 2006,

107:3555-3563.

8 张艳林, 曹勇军, 刘春风. 血管内皮钙黏蛋白参与动

脉粥样硬化形成的机制[J]. 国际脑血管病杂志, 2009,

17:53-56.

9 韩雅玲, 齐岩梅, 康建, 等. 纤维蛋白原诱导大鼠主动

脉平滑肌细胞增殖及趋化[J]. 中国动脉粥样硬化杂志,

2005, 13:409-413.

10 曹勇军, 钱进军, 刘春风. 纤维蛋白(原)、纤维蛋白(原)

降解产物及其基序拮抗剂与动脉粥样硬化[J]. 国际脑

血管病杂志, 2006, 14:290-293.

11 Keavney B, Danesh J, Parish S, et al. Fibrinogen and

coronary heart disease:test of causality by ‘Mendelian

randomization’[J]. Int J Epidemiol, 2006, 35:935-943.

12 J a e g e r BR, La b a r r e r e CA. Fi b r i n o g e n a n d

atherothrombosis:vulnerable plaque or vulnerable

Patient?[J]. Herz, 2003, 28:530-538.

13 Woodwa rd M, Lowe GDO, Rumley A, e t a l .

Fibrinogen as a risk factor for coronary heart disease

and mortality in middle-aged men and women:The

Scottish Heart Health Study[J]. Eur Heart J, 1998,

19:55-62.

14 Dansh J. Plasma fibrinogen level was correlation with

the risk of coronary disease, apoplexy and death risk

[J]. Cardiology, 2005, 1:16-19.

15 Fibr inogen St udie s Col labor at ion, Dane sh J,

Lewington S, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular

mortality:an individual participant Meta-analysis[J].

JAMA, 2005, 294:1799-1809.

16 Ernst E, Resch KL. Fibrinogen as a cardiovascular risk

factor:a Meta-analysis and review of the literature[J].

Ann Intern Med, 1993, 118:956-963.

17 刘春红, 王宏, 马雅静. 纤维蛋白原对缺血性脑卒中的

影响[J]. 中国动脉硬化杂志, 2004, 12:477-478.

18 East E, Baker D, Pryce G, et al. A role for the

plasminogen activator system in inflammation and

neurodegeneration in the central nervous system

during experimental allergic encephalomyelitis[J].

Am J Pathol, 2005,167:545-554.

19 Akassoglou K, Akpinar P, Murray S, et al. Fibrin is a

regulator of Schwann cell migration after sciatic nerve

injury in mice[J]. Neurosci Lett, 2003, 338:185-188.

20 Adams RA, Passino M, Sachs BD, et al. Fibrin

mechanisms and functions in ner vous system

pathology[J]. Mol Interv, 2004, 4:163-176.

21 Akassoglou K, Adams RA, Bauer J, et al. Fibrin

depletion decreases inflammation and delays the onset

of demyelination in a tumor necrosis factor transgenic

mouse model for multiple sclerosis[J]. Proc Natl Acad

Sci USA, 2004, 101:6698-6703.

22 Kirk J, Plumb J, Mirakhur M, et al. Tight junctional

abnormality in multiple sclerosis white matter affects

all calibres of vessel and is associated with bloodbrain

barrier leakage and active demyelination[J]. J

Pathol, 2003, 201:319-327.

23 Abe Y, Nakamura H, Yoshino O, et al. Decreased

neural damage after spinal cord injury in tPA-deficient

mice[J]. J Neurotrauma, 2003, 20:43-57.

24 Boudaoud L, Roussi J, Lor t at-Jacob S, et al.

Endothelial fibrinolytic reactivity and the risk of deep

venous thrombosis after spinal cord injury[J]. Spinal

Cord, 1997, 35:151-157.

25 P a u l J , S t r i c k l a n d S , Me l c h o r J P. Fi b r i n

deposition accelerates neurovascular damage and

neuroinflammation in mouse models of Alzheimer's

disease[J]. J Exp Med, 2007, 204:1999-2008.

26 Melchor JP, Pawlak R, Strickland S. The tissue

plasminogen activator-plasminogen proteolytic

cascade accelerates amyloid-β (Abeta) degradation

and inhibits Abeta-induced neurodegeneration[J]. J

Neurosci, 2003, 23:8867-8871.

27 Gveric D, Herrera BM, Cuzner ML. tPA receptors

and the fibrinolytic response in multiple sclerosis

lesions[J]. Am J Pathol, 2005, 166:1143-1151.

28 饶明利, 主编. 中国脑血管病防治指南[M]. 北京:人民

卫生出版社, 2007:34-35.